How ONL used iNebula to accelerate its Phase 2 trial
ONL discuss their collaboration on a recent Phase 2 rhegmatogenous retinal detachment (RRD) program. The panelists discuss the importance of partnering with a reading center that offers Voxeleron's iNebula platform - in particular for its real-time access to the image data as well as its AI-enabled endpoints. Featuring: Connie Change:…
How Allgenesis Evaluated Unique Endpoints to Advance its Phase
Allgenesis discuss their collaboration on a recent phase two study for diabetic macular edema (DME). The panelists highlight the importance of imaging and biomarkers in ophthalmology clinical trials and share their experiences working with Voxeleron's AI technology. Featuring: Tan Nguyen: Vice President of Research and Development at Allgenesis Biotherapeutics. Janet…
How Interoperability Drives Ophthalmic Clinical Trial Success for Voiant
Jason Slakter, MD and Hanna Coleman, MD of Voiant Clinical discuss how the unique interoperability of Voxeleron’s Orion platform helps drive ophthalmic clinical trial success. Want to learn more about Orion? Request a demo today or check out voxeleron.com/orion.
Voxeleron at ARVO 2024
Voxeleron at ARVO 2024 ARVO is upon us, and we look forward to visiting the pacific northwest again this year! It is, without doubt, a unique conference allowing for both formal and informal get-togethers, all with the shared objective of advancing ophthalmic research. In preparation for this, we’d like to…
Customer Spotlight: TI Image Selects Voxeleron for Device-Agnostic Ophthalmic Imaging Analysis
Explore our latest Customer Spotlight with TI Image, showcasing seamless onboarding and ongoing support in transitioning to Voxeleron's ophthalmic imaging solution.
Voxeleron Appoints New CEO and Secures Funding to Continue Growing Its Innovative Ophthalmic Image Analysis Platform
Seasoned life science industry veteran to drive the next phase of growth and market expansion AUSTIN, TX – March 13, 2024: Voxeleron, a cloud-based ophthalmic image analysis platform provider, today announced the appointment of Joanna Williams as its new Chief Executive Officer (CEO). With over 25 years of experience in…
Voxeleron is ISO 13485:2016 Certified
Voxeleron is now ISO 13485:2016 certified. This key accomplishment, complementing our existing SOC 2 certification and compliance to 21 CFR Part 11 and GDPR, reflects our commitment to quality in the development and delivery of our platform and services, and underlines our priority of data security, traceability and privacy. ISO…
Emerging Trends in HealthTech and Ophthalmology: Key Insights from MedTech
MedTech recently held its annual conference, showcasing the latest developments in the HealthTech market. Among the key takeaways were pivotal trends influencing the industry, shedding light on the crucial aspects that will redefine patient care, data privacy, collaboration, and the integration of artificial intelligence in healthcare. Navigating Ethical Gray…
Three Headaches in Ophthalmic Research You Can Avoid with Orion’s AI-driven Analysis Software
Three Headaches in Ophthalmic Research You Can Avoid with Orion by Voxeleron In the world of ophthalmic research and clinical trials, efficiency and accuracy are paramount to successful outcomes. As trials navigate through diverse image modalities and file formats, tackle time-consuming reads, and grapple with inflexible proprietary platforms, a solution…
The Download from ARVO 2023: AI and Interoperability Drive Breakthroughs in Ophthalmic Research
The Download from ARVO 2023: AI and Interoperability Drive Breakthroughs in Ophthalmic Research The American Association for Research in Vision and Ophthalmology (ARVO) recently held its annual conference, showcasing the latest developments in the industry. Among the key takeaways were the crucial roles of artificial intelligence (AI) and interoperability in…